← All organizations

Synvista Therapeutics, Inc

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 1, 2008

Defunct as of Apr 17, 2014

Timeline

1980s

Oct 1, 1986
Synvista Therapeutics, Inc— Founded

2010s

Apr 17, 2014
Synvista Therapeutics, Inc— Defunct

Drugs by trial phase (3 distinct, 14 trials)

Phase 3 (1 own, 0 via acquisition)

alagebrium

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (17)

NCT00782613Lead sponsorPhase 2Nov 1, 2008
NCT01417663CollaboratorPhase 2/Phase 3Nov 1, 2008
NCT00739687Lead sponsorPhase 2Aug 1, 2008
NCT00662116Lead sponsorPhase 2Mar 1, 2008
NCT00557518Lead sponsorPhase 2Nov 1, 2007
NCT00516646Lead sponsorPhase 2Aug 1, 2007
NCT00491543Lead sponsorPhase 2Jun 1, 2007
NCT00320502Lead sponsorPhase 2May 1, 2006
NCT00302250Lead sponsorPhase 2Feb 1, 2006
NCT00089713Lead sponsorPhase 2Mar 1, 2004
NCT00089713Study directorPhase 2Mar 1, 2004
NCT00277875Lead sponsorPhase 2Feb 1, 2004
NCT00043836Lead sponsorPhase 2Jul 1, 2002
NCT00045981Study directorPhase 2Oct 1, 2001
NCT00045981Lead sponsorPhase 2Oct 1, 2001

Details

Founded: Montvale, NJ, US Oct 1, 1986
Last known activity: Nov 1, 2008